M. ALADAĞ Et Al. , "TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV," 24th CONFERENCE OF APASL , İstanbul, Turkey, 2015
ALADAĞ, M. Et Al. 2015. TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV. 24th CONFERENCE OF APASL , (İstanbul, Turkey).
ALADAĞ, M., ALADAĞ, H., BİLGİÇ, Y., HARPUTLUOĞLU, M. M. M., ÇAĞIN, Y. F., ERDOĞAN, M. A., ... YAHYA, A.(2015). TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV . 24th CONFERENCE OF APASL, İstanbul, Turkey
ALADAĞ, MURAT Et Al. "TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV," 24th CONFERENCE OF APASL, İstanbul, Turkey, 2015
ALADAĞ, MURAT Et Al. "TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV." 24th CONFERENCE OF APASL , İstanbul, Turkey, 2015
ALADAĞ, M. Et Al. (2015) . "TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV." 24th CONFERENCE OF APASL , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={MURAT ALADAĞ Et Al. }, title={TELAPREVIR BASED TREATMENT SUCCESSFULLY PREVENTS POSTTRANSPLANT RELAPSE IN PATIENTS WITH CIRRHOTIC HCV}, congress name={24th CONFERENCE OF APASL}, city={İstanbul}, country={Turkey}, year={2015}}